logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tomasz Rutkowski

maria sklodowska-curie national research institute of oncology gliwice branch
H指数:20
被引数:1,422

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating tumor HPV DNA reappearance as an early indicator of recurrence after radiotherapy-based treatment for HPV-associated oropharyngeal cancer: analysis of more than 2000 assessments in 232 patients

HPV相关口咽癌经放疗为基础治疗后，循环肿瘤HPV DNA复发作为复发的早期指标：对232例患者超过2000次评估的分析

Oral Oncology
IF3.9
2026-09-090
OAAI
Iwona Agnieszka Jabłońska; Tomasz Wojciech Rutkowski; Urszula Kacorzyk; Marek Kentnowski; Natalia Vydra; Agnieszka Maria Mazurek
Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study

Nivolumab在头颈部复发或转移性鳞状细胞癌患者中的应用: 波兰多中心观察性研究的结果

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-11-050
OA
Rutkowski, Tomasz Wojciech; Kurczyk, Agata; Drosik-Rutowicz, Katarzyna; Kiprian, Dorota; Debicka, Izabella; Sierko, Ewa; Konopka-Filippow, Monika; Kazmierska, Joanna; Lukasiewicz-Grella, Monika; Czastkiewicz-Trawinska, Diana; Mrochem-Domin, Izolda; Ryniewicz-Zander, Iwona; Borysiewicz, Zuzanna; Chmielowska, Ewa; Jasiowka, Marek; Zrebiec-Figura, Monika; Karpinska, Agnieszka; Pacholczak-Madej, Renata; Les, Dominika; Pietruszka, Agnieszka; Lasinska, Izabela; Skladowski, Krzysztof
Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+HNSCC

探索性疗效和转化研究结果来自AHEAD-MERIT试验的安全性入组阶段，这是一项针对晚期HPV16+HNSCC的一线帕博利珠单抗联合固定抗原癌症疫苗BNT113的II期试验。

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Saba, N. F.; Klinghammer, K.; Castelluci, E.; Colevas, A. D.; Rutkowski, T.; Thurner, D.; Mueller-Richter, U.; Maio, M.; Grewal, J. S.; Ottensmeier, C. H. H.; Dias, J.; Yang, H.; Das, R.; Furlanetto, J.; Herzfeldt, A-K.; Kuehnle, M-C.; Ulges, A.; Alles, J.; Tuereci, Oe; Sahin, U.
A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma (R/M HNSCC)

一项I/IIa期、开放标签、剂量探索试验，旨在评估VB10.16联合pembrolizumab在不可切除的复发或转移性HPV16阳性头颈鳞状细胞癌（R/M HNSCC）患者中的安全性、免疫原性和抗肿瘤活性。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Khalique, S.; Oliva, M.; Even, C.; Dziadziuszko, R.; Dietz, A.; Italiano, A.; Melichar, B.; Martinez-Galan, J.; Brydoy, M.; Thouvenin, J.; Rutkowski, T.; Hitre, E.; Arnau, M. Guix; Criado, M. P. Lopez; Jurgens, T.; Bratland, A.
Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis

诊断时HPV相关口咽癌患者循环肿瘤HPV16 DNA水平的决定因素

SCIENTIFIC REPORTS
IF3.9
2023-12-013
OAAI
Kentnowski, Marek; Cortez, Alexander J.; Mazurek, Agnieszka M.; Mrochem-Kwarciak, Jolanta; Hebda, Anna; Kacorzyk, Urszula; Drosik-Rutowicz, Katarzyna; Chmielik, Ewa; Paul, Piotr; Gajda, Karolina; Lasinska, Izabela; Bobek-Billewicz, Barbara; d'Amico, Andrea; Skladowski, Krzysztof; Snietura, Miroslaw; Faden, Daniel L.; Rutkowski, Tomasz W.

研究方向

暂未获取到该数据
K
Krzysztof Składowski
H 指数:29论文数:310被引数:5,382
A
A. Wygoda
H 指数:16论文数:184被引数:1,091
B
B. Pilecki
H 指数:9论文数:87被引数:528
M
M. Hutnik
H 指数:6论文数:53被引数:112
J
Jolanta Mrochem‐Kwarciak
H 指数:11论文数:69被引数:353
M
M. Goleń
H 指数:7论文数:63被引数:345
A
Agnieszka Mazurek
H 指数:14论文数:49被引数:559
W
Widlak, P.
H 指数:0论文数:10被引数:0
B
B. Maciejewski
H 指数:29论文数:213被引数:5,460
M
Marek Kentnowski
H 指数:5论文数:36被引数:83